This guide explains diabetes insipidus, including common symptoms, hormone causes, diagnosis tests, and medical treatment ...
Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.
Please provide your email address to receive an email when new articles are posted on . Desmoda is the first oral solution approved to manage central diabetes insipidus, according to Eton ...
The FDA approved desmopressin acetate (Desmoda) oral solution for the management of central diabetes insipidus in adults and children, developer Eton Pharmaceuticals announced. The vasopressin analog ...
As you have seen, it has been a very active time at Eton. During the call, we will review fourth quarter results, provide ...
FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States. Precise ...
What Is Desmoda, and Why Does It Matter? The FDA has approved Desmoda (desmopressin acetate) oral solution for managing central diabetes insipidus (CDI) in adults and children. It is a liquid version ...
Detailed price information for Eton Pharmaceutcials Inc (ETON-Q) from The Globe and Mail including charting and trades.
25d
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution
DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on March 9thDESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing fo ...
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript March 19, 2026 Eton Pharmaceuticals, Inc. misses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results